Arcellx shares jump 6% in premarket after Gilead pact

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Arcellx Inc.

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply